PDCD1 and cancer: Immune checkpoint inhibitors (ICI), for instance, programmed cell death 1 (PD-1), programmed cell death ligand-1 (PD-L1), cytotoxic T lymphocyte antigen 4 (CTLA-4) have shown notably promise for the treatment of various cancers (8).